Medi Assist FY26: Revenue Up 25.1% to ₹923 Cr, EBITDA at ₹174.6 Cr, Debt-Free
Medi Assist Healthcare Services Limited reported FY26 consolidated operating revenue of ₹923.2 crore, up 25.1% YoY. EBITDA stood at ₹174.6 crore with a 19.3% margin. The company is now debt-free with ₹260.5 crore in free cash. Premiums administered reached ₹25,923.2 crore, and market share grew to 20.7%. Tech revenue surged 91.9% YoY.
The announcement includes significant financial highlights such as revenue growth, improved margins, debt-free status, and market share expansion, which are material for investors.
The company reported strong year-on-year growth in revenue and EBITDA, became debt-free, and expanded its market share, indicating positive financial and operational performance.
Medi Assist Healthcare Services Limited announced its financial results for the fourth quarter and the full fiscal year 2026. For FY26, the company reported a consolidated operating revenue of ₹923.2 crore, marking a significant year-on-year growth of 25.1%. The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at ₹174.6 crore, with an EBITDA margin of 19.3% for the fiscal year.
The company highlighted its strong financial performance, becoming debt-free with a free cash position of ₹260.5 crore. Group and Retail premiums administered reached ₹25,923.2 crore, a 22.8% year-on-year increase. Medi Assist also expanded its market share, with overall Group and Retail market share at 20.7% and Group market share at 33.7%.
Technologically, the company reported tech revenue growth of 91.9% year-on-year. Its AI-powered platform, MA ven Guard, identified approximately ₹540 crore in health insurance fraud, a 38.5% increase. The integration of Paramount is on track, with over 50% of PHS claims volume migration to MAtrix completed as of April 2026, aiming to be the primary processing engine by Q2FY27.
In Q4 FY26, operating revenue grew by 23.6% year-on-year to ₹243.2 crore, and EBITDA was ₹48.3 crore with a margin of 19.9%. The reported Profit After Tax (PAT) for FY26 was ₹89.3 crore, while the adjusted PAT, excluding exceptional items, was ₹68.8 crore. The company also noted a PUM (Policies Under Management) growth of 24.6% for PSU and 28.1% for Pvt & SAHI segments.
What to do with a filing like this
Medi Assist Healthcare Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medi Assist Healthcare Services Limited. Read the original for the full detail.